Overview

The HHS Section 504 analysis treats the one-year extension as a timing shift: modeled implementation costs move later, while benefits of full WCAG 2.1 conformance also arrive later. Using the 2024 RIA, HHS estimated annualized cost savings of $114.3 million at 7% or $93.3 million at 3%, alongside annualized foregone benefits of $204.6 million or $189.8 million. These are assumption-dependent model outputs, not observed social prices. The chapter also covers private-right-of-action risk, Title II overlap without merged tests, and future rulemaking as uncertainty.

Learning outcomes

The extension shifts modeled costs and benefits later; it does not necessarily reduce the amount of work recipients must do.
HHS’s dollar estimates are model outputs tied to the 2024 RIA, discount rates, time horizon, and assumptions—not observed universal outcomes.
The extension may reduce near-term litigation pressure, but Title II alignment does not merge legal tests and future rulemaking remains uncertain.

Keywords

Section 504CostsBenefitsLitigationTitle IIRulemaking

The Cost of Waiting: Litigation, Benefits, and Policy Trade-Offs

The HHS extension changes more than a date on a compliance calendar. It changes when some implementation costs are expected to occur, when the benefits of full WCAG 2.1 conformance are expected to appear, and how recipients manage uncertainty about litigation and future rulemaking. This chapter reads those consequences together. Its purpose is not to declare the extension good or bad, but to give readers a fair comparison: what does the original schedule assume, what does the one-year shift postpone, and which conclusions remain conditional?

The extension moves both costs and benefits

HHS evaluates the 2026 interim final rule against a baseline in which the 2024 final rule would take effect on its original implementation timetable. In that baseline, recipients would incur initial costs such as familiarization, testing, and remediation during the first two or three years—two years for larger recipients and three years for smaller recipients. From the fourth year onward, the analysis assumes continuing implementation costs that do not vary from year to year. The benefits grow during the first implementation period as recipients complete the initial work. Later, some benefits remain steady, such as time savings from more accessible websites, while benefits associated with improved education for students with disabilities continue to grow as more students complete accessible curricula.

The extension changes the timing of that modeled path. HHS says that pushing implementation out by one year eliminates the first year's costs and benefits in the model and adds another year of costs and benefits in the future. This is a timing shift, not a claim that the work or its benefits vanish. Costs are pushed later, which can reduce their present value. Benefits are pushed later too, which means people with disabilities may wait longer for the uniform technical-standard benefits and those future benefits are discounted in the calculation.

The numbers make the two-sided effect visible. Using estimates from the 2024 final rule, HHS calculates that a one-year delay would reduce annualized costs by $114.3 million under a 7 percent discount rate or $93.3 million under a 3 percent rate. It estimates discounted total cost savings of $803.1 million at 7 percent or $796 million at 3 percent. These are cost savings in the model because implementation spending moves farther into the future; they are not necessarily permanent reductions in the amount of work recipients must do.

HHS also estimates foregone accessibility benefits. The annualized reduction is $204.6 million at 7 percent or $189.8 million at 3 percent. The discounted total foregone benefits are $1,436.8 million at 7 percent or $1,619.2 million at 3 percent, all reported in constant 2022 dollars. The fact that the 3 percent total is larger than the 7 percent total is not an inconsistency. A lower discount rate reduces the amount by which future benefits are discounted, so the same delayed benefit stream can have a higher present value under that assumption.

HHS summarizes the result as a net decrease in benefits after accounting for the modeled cost savings: $90.2 million or $96.5 million on an annualized basis, and $633.7 million or $823.2 million on a discounted total basis, depending on the discount rate. These figures should be read as outputs of the comparison, not as an observed social price of the rule. They depend on the 2024 RIA's baseline, time horizon, discounting, and assumptions about how costs and benefits unfold.

Published by DeepMox

FAQ

Are the HHS Section 504 extension’s cost savings permanent reductions?

Not necessarily. HHS models lower present costs because implementation spending moves later; it does not conclude that recipients will perform less total work.

Does moving HHS Section 504 dates eliminate litigation risk?

No. HHS changed the regulatory dates partly because private-right-of-action and litigation pressure mattered, but it did not promise non-enforcement or immunity from every claim.

Does Title II coverage merge with HHS Section 504?

No. Title II alignment can reduce coordination confusion for some entities, but it does not merge coverage tests or eliminate the need to identify the authority and facts involved.

Previous8 minHHS Section 504: Access Before the Date

Next13 minHHS Section 504: Delay the Clock

HHS Section 504: Cost of Waiting

The Cost of Waiting: Litigation, Benefits, and Policy Trade-Offs

The extension moves both costs and benefits

FAQ